Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04720209

Taking AIM at Breast Cancer

Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to determine whether a 16-week exercise program for individuals with breast cancer and have completed treatment (i.e., surgery, chemotherapy, or radiation) for breast cancer will decrease inflammation in fat tissue.

Detailed description

This study is about using different types of exercise to reduce inflammation in fat tissue in an effort to minimize the risk of cancer recurrence related to being overweight or obese. The investigators hope to learn whether participating in a specific exercise program can cause inflammation in the fat tissue to decrease. The names of the study interventions involved in this study are: * Circuit-style aerobic and resistance exercise (CARE) * Traditional aerobic and resistance exercise (TARE) The research study procedures include screening for eligibility, and study treatment including evaluations and follow up visits. The study treatment will be for 4 months and participants will followed for 8 months. The total time for participation in this study will be about 12 months. It is expected that about 300 people will take part in this research study.

Conditions

Interventions

TypeNameDescription
OTHERCARECARE is a 16-week, supervised, periodized AE and RE program performed in a circuit fashion 3 days/week on-site
OTHERTARETARE is a 16- week, supervised AE and RE program consisting of three sessions per week on-site
OTHERHome-Based StretchingThis group will perform a home-based program of the same stretches utilized in the CARE and TARE groups.

Timeline

Start date
2021-08-13
Primary completion
2026-08-31
Completion
2026-09-15
First posted
2021-01-22
Last updated
2025-09-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04720209. Inclusion in this directory is not an endorsement.

Taking AIM at Breast Cancer (NCT04720209) · Clinical Trials Directory